New antibody shows promise against tough liver virus
Disease control
Completed
This study tested an experimental drug called HH-003 in 101 adults with chronic hepatitis delta, a serious liver infection. The drug is an antibody that targets the hepatitis B virus, which the delta virus needs to survive. The main goal was to see if the treatment could lower vi…
Phase: PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC